Table 3.
Variables | Female | Male |
---|---|---|
Triglyceride (mg/dL) | ||
Pre | 111 ± 18 | 117 ± 8 |
Post | 119 ± 21 | 131 ± 23 |
Cholesterol (mg/dL) | ||
Pre | 210 ± 11 | 213 ± 12 |
Post | 209 ± 11 | 228 ± 12 |
HDL (mg/dL) | ||
Pre | 60 ± 7 | 48 ± 8 |
Post | 58 ± 7 | 48 ± 8 |
VLDL (mg/dL) | ||
Pre | 27 ± 5 | 31 ± 5 |
Post | 25 ± 5 | 38 ± 5 |
LDL (mg/dL) | ||
Pre | 123 ± 10 | 132 ± 11 |
Post | 125 ± 11 | 141 ± 11 |
Apo A (mg/dL) | ||
Pre | 169 ± 12 | 154 ± 12 |
Post | 154 ± 13 | 151 ± 13 |
Apo B (mg/dL) | ||
Pre | 93 ± 6b | 111 ± 7a |
Post | 91 ± 6b | 115 ± 7a |
Leptin (ng/mL) | ||
Pre | 35 ± 3a | 8 ± 3b |
Post | 32 ± 3a | 10 ± 4b |
Interleukin-1α (pg/mL) | ||
Pre | 1.30 ± 0.18c | 1.83 ± 0.09ab |
Post | 1.43 ± 0.18bc | 2.00 ± 0.09a |
C-reactive protein (mg/dL) | ||
Pre | 4.16 ± 0.56 | 3.34 ± 0.67 |
Post | 3.13 ± 0.56 | 2.35 ± 0.67 |
Antioxidant capacity (mM) | ||
Pre | 0.79 ± 0.05b | 0.83 ± 0.05b |
Post | 0.96 ± 0.06a | 1.10 ± 0.06a |
Malondialdehyde (μM) | ||
Pre | 29 ± 7b | 56 ± 8a |
Post | 13 ± 7c | 22 ± 8bc |
a,cMeans with unlike superscript are significantly (P ≤ 0.05) different from each other.